GTBiopharma
Julianne Feola is a clinical research manager currently leading a team at the Minneapolis Heart Institute Foundation, focusing on heart failure, electrophysiology, and gene therapy trials. Julianne's extensive experience includes roles as a clinical operations consultant and director at GT Biopharma, overseeing a Phase 1 immunooncology trial, and developing regulatory documentation. Previous positions at the University of Minnesota Medical School and the Masonic Cancer Center involved managing research programs and providing regulatory oversight for multisite studies. Julianne has also contributed to the field through editorial roles and educational support, highlighted by a Ph.D. in Neuroscience from the University of Rochester and additional degrees in Neuroscience, Psychology, and Chemistry.
This person is not in any teams
This person is not in any offices
GTBiopharma
GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia, and multiple solid tumors by leveraging their proprietary NK cell engager (TriKE™) platform technology.